← SynDRA
DOCOSANOL
SynDRA canonical compound SYN0022996 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | LPL | TLR7 |
|---|
| Mechanism of action | lipase clearing factor inhibitor |
|---|
| Indication | cold sore |
|---|
| Disease area | dental |
|---|
All known targets
- EBV BLLF1
- LPL
- TLR7
- gB
- gC
- gD
- gE
- gG
- gH
- gI
- gJ
- gK
Mechanisms of action (all sources)
- lipase clearing factor inhibitor
- Modulator
- gN INHIBITOR
- gM INHIBITOR
- gE INHIBITOR
- gH INHIBITOR
- gJ INHIBITOR
- gG INHIBITOR
- gI INHIBITOR
- gL INHIBITOR
- gB INHIBITOR
- GC INHIBITOR
Drug classes
- Anti-Infective Agents
- Antiviral Agents
ATC classes
- D06B · CHEMOTHERAPEUTICS FOR TOPICAL USE
Cross-references
Synonyms
- abreva
- behenic alcohol
- behenyl alcohol
- docosyl alcohol
- 1-Docosanol
- N-docosanol
- Behenic alcohol
- Behenyl alcohol
- Lidakol
- Stenol 1822
- NSC-8407
- Abreva
- Debat
- Doconsanol
- Erazaban
- Healip
- Herepair
- Lidavol
- Tadenan
- Docosanol [USAN]
- Docosyl alcohol
- IK 2
- Lanette 22
- NAA 422
- Stenol 1822A
- Abreva (TN)
- Docosanol (USAN)
- Docosanol (VAN)
- Erazaban (TN)
- IK.2
- N-Docosanol
- Nacol 22-97
- V-1326;BEHENYL ALCOHOL, 98%
- Docosan-1-ol
- Behenyl alcohol, Abreva, 1-Docosanol, Docosanol
- Behenyl alcohol, AI3-36489, Behenic alcohol, 1-Docosanol, Docosyl alcohol, IK-2, Tadenan
- 1-DOCOSANOL
- NSC 8407
Look up DOCOSANOL in the interactive SynDRA portal →